Nebulized neostigmine/atropine versus nebulized lidocaine for post-dural puncture headache after cesarean delivery
Official title: Comparison of Nebulized Neostigmine/Atropine Versus Lignocaine in Treating Acute Post-dural Puncture Headache Following Subarachnoid Block in Parturient Undergoing Elective Cesarean Section. A Randomized, Clinical Trial.
Run by Minia University · NCT06824025 · Data updated 2026-11-12
This trial tests whether inhaled (nebulized) neostigmine with atropine relieves post-dural puncture headache better than inhaled lidocaine in women who develop headache after spinal anesthesia for elective cesarean delivery.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 35 Years |
| Sex | Women only |
| Enrollment | 111 (estimated) |
| Sponsor | Minia University Academic / other |
| Locations | 1 site (Minya) |
| Status | Recruiting |
| Started | February 20, 2025 |
| Main results expected | January 1, 2027 |
| Study ends | January 5, 2027 |
| Registry record updated | August 12, 2026 |
| Trial ID | NCT06824025 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18–35 who develop moderate-to-severe post-dural puncture headache after elective cesarean delivery under spinal anesthesia (VAS ≥4 and Lybecker score ≥2).
✕Probably not a fit
Patients with pregnancy-induced hypertension, active or historical bronchial asthma, prior migraine or trigeminal neuralgia, postpartum hemorrhage, emergency cesarean section, need for conversion to general anesthesia, failed spinal anesthesia, or those who refuse participation are not eligible and are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, randomized interventional early phase I trial enrolls parturients who develop post-dural puncture headache after elective cesarean section under spinal anesthesia. Eligible women (aged 18–35) with moderate-to-severe headache (VAS ≥4 and Lybecker score ≥2) are randomized to receive nebulized neostigmine/atropine or nebulized lidocaine (total 4 ml). Headache intensity, need for rescue analgesia, and adverse events are followed after treatment to compare symptom relief and safety. The trial is conducted at Minia University and focuses on short-term headache outcomes and tolerability of the inhaled interventions.
Why it matters
Potential benefit: If successful, this noninvasive inhaled treatment could provide faster relief of PDPH symptoms and reduce the need for invasive procedures like an epidural blood patch.
How similar studies have gone: This inhaled neostigmine/atropine approach is largely novel for PDPH and prior related therapies (topical/local agents and systemic adjuvants) have shown mixed or limited evidence of benefit.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-35 years old parturient with post partum headache after elective CS under spinal anesthesia with visual analog score (VAS) ≥ 4 \[14\] and Lybecker classification score ≥ 2 Exclusion Criteria: * Pregnancy induced hypertension * Emergency C.S * Asthmatic candidates * Previous history of migraine or trigeminal neuralgia * History of bronchial asthma * Post partum hemorrhage * Need for GA , failed spinal anesthesia * Patient refusal
Where it's running
-
Minia University
Minya, Egypt Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Epidural hydroxyethyl starch to prevent post-dural puncture headache in parturients
This study tests whether filling the epidural space with hydroxyethyl starch can help prevent post-dural puncture headaches in women who had an accidental dural puncture during epidural anesthesia for labor or cesarean delivery.
-
Predicting Post-Dural Puncture Headache After Spinal Anesthesia in Cesarean Deliveries
This study tests whether changes in optic nerve sheath diameter after spinal anesthesia can predict who will develop a post-dural puncture headache in pregnant women having an elective cesarean.
-
Treating post-dural puncture headache with theophylline, sumatriptan, or gabapentin
This trial will try theophylline, sumatriptan, and gabapentin to see which best relieves moderate-to-severe post-dural puncture headache in adults aged 21–50.
-
Sphenopalatine ganglion block versus epidural blood patch for post-dural puncture headache
This test compares a sphenopalatine ganglion block and an epidural blood patch to see which relieves post-dural puncture headaches better in adults whose pain hasn't improved after 24 hours of usual treatment.
-
Exploring causes and treatments for postural puncture headache
This study is trying to understand what causes post-dural puncture headaches and how treatments like epidural blood patches can help people who get them after a lumbar puncture.
-
Impact of altitude on headaches after cesarean delivery
This study is testing how living at different altitudes affects the headaches that women experience after having a cesarean delivery with spinal anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.